↓ Skip to main content

Cochrane Database of Systematic Reviews

Ursodeoxycholic acid for primary biliary cirrhosis

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Citations

dimensions_citation
115 Dimensions

Readers on

mendeley
160 Mendeley
Title
Ursodeoxycholic acid for primary biliary cirrhosis
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd000551.pub3
Pubmed ID
Authors

Jelena S Rudic, Goran Poropat, Miodrag N Krstic, Goran Bjelakovic, Christian Gluud

Abstract

Ursodeoxycholic acid is administered to patients with primary biliary cirrhosis, a chronic progressive inflammatory autoimmune-mediated liver disease with unknown aetiology. Despite its controversial effects, the U.S. Food and Drug Administration has approved its usage for primary biliary cirrhosis.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 3 2%
Chile 1 <1%
Indonesia 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 153 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 14%
Student > Master 20 13%
Student > Ph. D. Student 16 10%
Researcher 15 9%
Student > Postgraduate 10 6%
Other 27 17%
Unknown 50 31%
Readers by discipline Count As %
Medicine and Dentistry 64 40%
Biochemistry, Genetics and Molecular Biology 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Nursing and Health Professions 6 4%
Agricultural and Biological Sciences 3 2%
Other 15 9%
Unknown 58 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2023.
All research outputs
#1,711,596
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#3,663
of 12,090 outputs
Outputs of similar age
#14,653
of 286,588 outputs
Outputs of similar age from Cochrane database of systematic reviews
#51
of 197 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,588 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.